news › trial-shows-promise-treating-neuroblastoma
… Dr. Leonid Metelitsa , professor of pediatrics – oncology, both at Baylor College of Medicine and Texas Children’s … and this clinical trial is helping to determine how to best implement it for patients.” The key aims of the …
about-us › ... › legacy-of-excellence
… by the end of his second year to enter medical school. He combined his final undergraduate courses with medical … toward national and international acclaim as one of the best medical schools in the United States. One of his …
departments › ... › projects-conducted-by-current-fellows
… Tetrahydrocannabinol (THC) containing products have become more readily available in Texas over the past several … adjustment for confounders such as illness severity and site of evaluation, disparities persist, particularly for … agree debriefing after global health experience is best practice and created a checklist tool. This study aims …
news › neurological-disorder-linked-gene-mutations
… Shashi, professor of pediatrics at the Duke Clinical Site of the Undiagnosed Disease Network (UDN), connected us … of proteins – for another in the protein made by the gene. Both the nonsense and the missense mutations are de novo , …
education › ... › administration
… healthcare workforce grounded in evidence-based care and competent interprofessional practice. … Vision: … The BCM … 679-4500, or by using information available on SACSCOC’s website ( www.sacscoc.org ). … Article 1.3 Organizational … and evaluation, coordinates self studies and site visits by accrediting agencies, and promotes Health …
news › baylor-college-of-medicine-receives-30-million-lead-gift-for-bold-expansion-plans
… and The Cullen Trust for Higher Education contributed a combined total of $30 million to build the new Cullen Tower, … at Baylor, one of the nation’s top-ranked medical training sites. They are joined by other key historical partners, …
news › repair-drive-precision-gene-therapy-for-liver-disorders
… be expressing,” Lagor explained. “Using Repair Drive, we come in and kill off the weeds, or the unhealthy cells. In … also the wide variety of gene edits to the intended target site. Many people are unaware of the complexities of performing targeted gene insertion. There …
healthcare › clinical-trials › h-44850
… … Primary objective: To assess the efficacy of MTG201 in combination with nivolumab in patients with relapsed … the safety and tolerability of MTG201 when given in combination with nivolumab; • To assess the disease control … of the next subject. Patients will return to the study site weekly for the first month of treatment, then every two …
about-us › ... › smoking-and-vaping
… by more strictly regulating the marketing and sale of both traditional and e-cigarettes, and various advocacy … at Baylor St. Luke’s Medical Center is one of only two sites in the state of Texas that has recently begun …
departments › ... › potential-bioterrorism-agents
… by Category Category A Category B Category C       Botulism   Hendra   Cholera     E. coli O157:H7   Hantavirus … and Treatment Evaluation Unit (VTEU), one of only nine such sites nationwide. The VTEU is funded by the NIAID component …
Back to topback-to-top